Developer docs
API playgroundTry for free, no card

Search company profiles

Syntho Pharmaceuticals

Full company profile

uuid003acmh

Namestring
Syntho Pharmaceuticals
Legal namestring
Syntho Pharmaceuticals Pvt. Ltd.
Websiteurl
eyepharma.in
Company typeenum
Private
Founded yearint
1975
Descriptiontext

Syntho Pharmaceuticals Pvt. Ltd. is a privately held, founder-controlled specialty pharmaceutical company headquartered in Lucknow, Uttar Pradesh, that develops, manufactures, and commercializes branded ophthalmic products for the Indian market and generic ophthalmic formulations for export markets. The company operates a WHO GMP certified production plant with an independent QC section and ISO 9001:2015 certification, producing eye drops and ointments across antibiotics, corticosteroids, NSAIDs, lubricants, and anti-glaucoma categories under brands such as MOSS, THOMOXX, ATROCIN, DEXCIN, and Obra.

The company runs a sales-led go-to-market model in India, deploying a network of medical representatives targeting ophthalmologists in cities including Lucknow, Delhi, Haryana, Jaipur, Bikaner, and Jodhpur, supported by a claimed distribution network of 10,000+ distributors and a contact database of 15,000+ ophthalmologists. Internationally, Syntho ships generic ophthalmic drops and ointments through export houses, providing dossiers, Certificates of Analysis, and Certificates of Pharmaceutical Product (COPP) under USP and BP standards across markets spanning several countries.

The business makes money primarily through one-time sales of branded pharmaceutical SKUs at quote-based pricing, with no subscription, licensing, or recurring revenue model disclosed. Founded in 1975 by Mr. Dinesh Agarwal and led today by a family management team, Syntho has 45+ years of lineage, 11-50 employees, and no external institutional funding on record. The company's stated differentiators are regulatory compliance, distribution depth, and longevity in a specialized therapeutic category, rather than proprietary technology or differentiated pricing power.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLucknow, India
HQ citystring
Lucknow
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic pharmaceuticals, eye drops manufacturing, ear drops formulations, pharmaceutical manufacturing India, ophthalmic solutions
Industry3 codes
PRIMARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIABAF
Ophthalmic & Otic Generics
SECONDARYHLAIADAF
Eye, Ear & Nasal Care
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Ophthalmic Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Ophthalmic Pharmaceutical Products
TypeOne Time License
Description

Sale of branded pharmaceutical products for ophthalmology including eye drops and ointments through domestic distribution and export channels

eyepharma.in
2Export Products
TypeOne Time License
Description

Generic ophthalmic drops and ointments exported to several countries through export houses, with documentation including dossiers, Certificate of Analysis, and COPP

eyepharma.in
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Quote-based pharmaceutical pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Contact-based pricing through Request a Free Quote form; price list available but not publicly displayed on website

eyepharma.in
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Syntho Pharmaceuticals develops, manufactures, and commercializes branded ophthalmic pharmaceutical products including eye drops, eye ointments, and ear drops for the Indian domestic market, and exports generic ophthalmic and otic formulations to international markets through export houses. The product portfolio spans antibiotics, corticosteroids, NSAIDs, lubricants, glaucoma medications, and combination products, manufactured at a WHO GMP certified facility in Lucknow, India.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Syntho Pharmaceuticals is a specialty pharmaceutical company focused on developing, manufacturing, and commercializing branded ophthalmic pharmaceutical products. The company's product portfolio consists of over 30 distinct eye and ear drop formulations and ointments sold in India, along with generic ophthalmic products for international export. The India market portfolio includes antibiotic formulations (ATROCIN, DEXCIN, Mycin, Ktromoxx), corticosteroid combinations (CORTECYCLINE, Obra-D, F-LONE), NSAID formulations (NSAID-N, Phenosulf), lubricant eye drops (MOSS family including MOSS, MOSS FRESH Gel, MOSS PG, MOSS PLUS), glaucoma treatments (Timo-5, THOMOXX, THOMOXX-L), and combination products (Mezol, NUGEN, OLOTAD, P-LONE, QUGAT, Phentrop, HY-MOSS). The company also exports generic ophthalmic formulations internationally under USP and BP standards. The portfolio spans multiple therapeutic categories including antibiotics, anti-inflammatory agents, lubricants, and glaucoma medications.

Product and service49 records
1ATROCIN P Eye Ointment
CategoryOphthalmic Pharmaceutical - Antibiotic
Description

Branded ophthalmic ointment formulation in the antibiotic category, sold through Syntho's domestic distribution network in India for treatment of eye conditions.

2ATROCIN Eye Ointment
CategoryOphthalmic Pharmaceutical - Antibiotic
Description

Branded ophthalmic ointment formulation in the antibiotic category for the Indian domestic market, distributed through Syntho's medical representatives and distributors.

3CORTECYCLINE Eye Ointment
CategoryOphthalmic Pharmaceutical - Corticosteroid
Description

Branded ophthalmic ointment in the corticosteroid combination category for Indian domestic ophthalmic use.

4DEXCIN Eye & Ear Drops
CategoryOphthalmic/Otic Pharmaceutical - Combination
Description

Combination ophthalmic and otic drop formulation in the antibiotic/corticosteroid category for Indian domestic treatment of eye and ear conditions.

5DEXCIN-M Eye Drops
CategoryOphthalmic Pharmaceutical - Combination
Description

Branded ophthalmic combination drop formulation in the antibiotic/corticosteroid category, sold in India.

6F-LONE Eye Drops
CategoryOphthalmic Pharmaceutical - Corticosteroid
Description

Corticosteroid ophthalmic drop formulation for the Indian domestic market for treatment of inflammatory eye conditions.

7HY MOSS Eye Drops
CategoryOphthalmic Pharmaceutical
Description

Branded ophthalmic drop formulation in the HY MOSS / MOSS family for Indian domestic use.

8HY MOSS T Drops
CategoryOphthalmic Pharmaceutical
Description

Newly launched branded ophthalmic drop formulation in the HY MOSS product family, sold in India.

9Ktromoxx Eye Drops
CategoryOphthalmic Pharmaceutical - Antibiotic
Description

Antibiotic ophthalmic drop formulation distributed in the Indian domestic market through Syntho's field force and distributors.

10LOW-DEX Eye & Ear Drops
CategoryOphthalmic/Otic Pharmaceutical - Corticosteroid
Description

Corticosteroid ophthalmic and otic drop formulation for the Indian domestic market.

11Mezol Eye Drops
CategoryOphthalmic Pharmaceutical - Combination
Description

Combination ophthalmic drop formulation sold in the Indian domestic market for treatment of multiple eye conditions.

12MOSS FRESH Gel Lubricant Eye Drops
CategoryOphthalmic Pharmaceutical - Lubricant
Description

Gel-based lubricant eye drop in the MOSS family for dry eye relief, sold in India.

13MOSS Lubricant Eye Drops
CategoryOphthalmic Pharmaceutical - Lubricant
Description

Lubricant eye drop formulation in the MOSS family for dry eye relief, sold in India.

14MOSS PG Lubricant Eye Drops
CategoryOphthalmic Pharmaceutical - Lubricant
Description

Lubricant eye drop formulation in the MOSS family, distributed in India for dry eye conditions.

15MOSS PLUS Lubricant Eye Drops
CategoryOphthalmic Pharmaceutical - Lubricant
Description

Lubricant eye drop formulation in the MOSS family for dry eye relief, sold in India.

16Mycin Eye Drops
CategoryOphthalmic Pharmaceutical - Antibiotic
Description

Antibiotic ophthalmic drop formulation in the Indian domestic market for treatment of bacterial eye infections.

17NS-AID Eye Drops
CategoryOphthalmic Pharmaceutical - NSAID
Description

NSAID ophthalmic drop formulation sold in India for inflammation-related eye conditions.

18NSAID-N Eye Drops
CategoryOphthalmic Pharmaceutical - NSAID
Description

NSAID ophthalmic drop formulation distributed in India.

19NUGEN Eye & Ear Drops
CategoryOphthalmic/Otic Pharmaceutical - Combination
Description

Combination ophthalmic and otic drop formulation for the Indian domestic market.

20Obra-D Eye Ointment
CategoryOphthalmic Pharmaceutical
Description

Ophthalmic ointment formulation in the Obra family for Indian domestic ophthalmic treatment.

21Obra Eye Drops & Ointment
CategoryOphthalmic Pharmaceutical
Description

Ophthalmic drop and ointment combination product in the Obra family, sold in India.

22Obra-F Eye Drops
CategoryOphthalmic Pharmaceutical
Description

Ophthalmic drop formulation in the Obra family sold in India.

23OLOTAD Eye Drops
CategoryOphthalmic Pharmaceutical - Combination
Description

Combination ophthalmic drop formulation sold in India for treatment of eye conditions.

24P-LONE Eye Drops
CategoryOphthalmic Pharmaceutical - Corticosteroid
Description

Corticosteroid ophthalmic drop formulation sold in India.

25Phenosulf Eye Drops
CategoryOphthalmic Pharmaceutical - NSAID
Description

NSAID ophthalmic drop formulation distributed in India.

26Phentrop Eye Drops
CategoryOphthalmic Pharmaceutical
Description

Newly launched branded ophthalmic drop formulation sold in India.

27QUGAT Eye Drops
CategoryOphthalmic Pharmaceutical - Combination
Description

Combination ophthalmic drop formulation sold in India.

28THOMOXX Eye Ointment
CategoryOphthalmic Pharmaceutical
Description

Ophthalmic ointment formulation in the THOMOXX family for the Indian domestic market.

29THOMOXX Eye Drops
CategoryOphthalmic Pharmaceutical
Description

Ophthalmic drop formulation in the THOMOXX family for the Indian domestic market.

30THOMOXX-L Eye Drops
CategoryOphthalmic Pharmaceutical
Description

Newly launched ophthalmic drop formulation in the THOMOXX family for the Indian domestic market.

31Timo-5 Eye Drops
CategoryOphthalmic Pharmaceutical - Glaucoma
Description

Glaucoma treatment ophthalmic drop formulation (beta-blocker) sold in India.

32Calodin Eye Drops
CategoryOphthalmic Pharmaceutical
Description

Branded ophthalmic drop formulation sold in India through Syntho's distribution network.

33Chloramphenicol Otic Solution 0.1% USP (Export)
CategoryOtic Pharmaceutical - Antibiotic (Export)
Description

Generic antibiotic otic solution exported internationally under USP standards for treatment of ear infections.

34Chloramphenicol Eye Drops 0.5% USP (Export)
CategoryOphthalmic Pharmaceutical - Antibiotic (Export)
Description

Generic antibiotic ophthalmic drops exported internationally under USP standards for bacterial eye infections.

35Ciprofloxacin Eye Drops 3mg/ml USP (Export)
CategoryOphthalmic Pharmaceutical - Antibiotic (Export)
Description

Fluoroquinolone antibiotic ophthalmic drops exported under USP standards for bacterial eye infections.

36Clotrimazole Ear Drops 1% w/v (Export)
CategoryOtic Pharmaceutical - Antifungal (Export)
Description

Antifungal otic drops exported internationally for treatment of fungal ear infections.

37Dexamethasone 0.1% w/v & Chloramphenicol 1% w/v Eye Drops (Export)
CategoryOphthalmic Pharmaceutical - Combination (Export)
Description

Combination corticosteroid and antibiotic ophthalmic drops exported internationally for inflammatory eye conditions complicated by bacterial infection.

38Dexamethasone Eye Drops 0.1% w/v (Export)
CategoryOphthalmic Pharmaceutical - Corticosteroid (Export)
Description

Corticosteroid ophthalmic drops exported under USP standards for inflammatory eye conditions.

39Timolol Maleate Ophthalmic Solution 0.5% USP (Export)
CategoryOphthalmic Pharmaceutical - Glaucoma (Export)
Description

Beta-blocker ophthalmic drops exported under USP standards for treatment of glaucoma and ocular hypertension.

40Cromolyn Sodium Ophthalmic Solution USP 4% w/v (Export)
CategoryOphthalmic Pharmaceutical - Antiallergic (Export)
Description

Mast cell stabilizer ophthalmic drops exported under USP standards for treatment of allergic conjunctivitis.

41Chloramphenicol Ophthalmic Ointment USP 1% w/v (Export)
CategoryOphthalmic Pharmaceutical - Antibiotic (Export)
Description

Generic antibiotic ophthalmic ointment exported internationally under USP standards for eye infections.

42Tetracycline Eye Ointment 1% USP (Export)
CategoryOphthalmic Pharmaceutical - Antibiotic (Export)
Description

Generic antibiotic ophthalmic ointment exported under USP standards for bacterial eye infections.

43Prednisolone Sodium Phosphate Eye Drops BP 0.1% w/v (Export)
CategoryOphthalmic Pharmaceutical - Corticosteroid (Export)
Description

Corticosteroid ophthalmic drops exported under BP standards for treatment of ocular inflammation.

44Betamethasone Ear Drops 0.1% (Export)
CategoryOtic Pharmaceutical - Corticosteroid (Export)
Description

Corticosteroid otic drops exported internationally for treatment of inflammatory ear conditions.

45Carboxymethyl Cellulose 1% (Export)
CategoryOphthalmic Pharmaceutical - Lubricant (Export)
Description

Lubricant ophthalmic drops exported internationally for dry eye relief.

46Chloramphenicol Ear Drops 5% (Export)
CategoryOtic Pharmaceutical - Antibiotic (Export)
Description

Generic antibiotic otic drops exported internationally for bacterial ear infections.

47Ciprofloxacin Eye Drops BP 0.2% w/v (Export)
CategoryOphthalmic Pharmaceutical - Antibiotic (Export)
Description

Fluoroquinolone antibiotic ophthalmic drops exported under BP standards.

48Moxifloxacin Ophthalmic Solution USP (Export)
CategoryOphthalmic Pharmaceutical - Antibiotic (Export)
Description

Fourth-generation fluoroquinolone ophthalmic drops exported under USP standards for bacterial eye infections.

49Tobramycin + Dexamethasone Eye Drops (Export)
CategoryOphthalmic Pharmaceutical - Combination (Export)
Description

Combination antibiotic and corticosteroid ophthalmic drops exported internationally for inflammatory eye conditions with bacterial infection risk.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Delhi Ophthalmological Society (DOS)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-03-20
Description

Syntho Pharmaceuticals participated as a supporter in the Delhi Ophthalmological Society Midterm Conference 2021 held on March 20-21, 2021 at Hotel Ashoka, New Delhi. The two-day event saw participation from ophthalmologists across India and abroad through online and offline sessions.

eyepharma.in
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Active involvement in knowledge sharing and development through various ophthalmological societies including Glaucoma Society of India (GSI), UP State Ophthalmological Society (UPSOS), UK State Ophthalmological Society (UKSOS), Delhi Ophthalmological Society (DOS), and All India Ophthalmological Society (AIOS).

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Large Indian pharmaceutical company with ophthalmic products spanning glaucoma, anti-infectives, and dry eye. Competes with Syntho for ophthalmologist share in India and generic ophthalmic exports.

TypeBroad incumbent
Description

Global leader in eye care with a broad ophthalmic pharmaceutical and surgical portfolio. While significantly larger and focused on premium branded products, it competes indirectly with Syntho for ophthalmologist mindshare in India and serves as the innovation benchmark that domestic players chase.

TypeDirect peer
Description

India-based specialty pharmaceutical company focused exclusively on ophthalmology, ENT, and dermatology. Closely comparable as a smaller, specialty-focused Indian pharma with similar product categories (eye drops, ointments) and sales-led GTM via medical representatives.

4Centaur Pharmaceuticals
TypeDirect peer
Description

Indian pharmaceutical manufacturer with a dedicated ophthalmic division producing eye drops and ophthalmic preparations. Comparable as a domestic specialty player in the Indian ophthalmic market.

TypeDirect peer
Description

Indian specialty pharmaceutical company with ophthalmology and ENT product lines. Competes in similar ophthalmic therapeutic categories and exports to multiple international markets through documentation similar to Syntho's dossier/COA/COPP approach.

6Sun Pharmaceutical Industries
TypeDirect peer
Description

India's largest pharmaceutical company with a substantial ophthalmic franchise (Sun Pharma's ophthalmic division markets branded and generic eye drops and ointments). Direct competitor in Indian ophthalmic prescriptions and exports, with significantly larger scale and R&D budget.

TypeDirect peer
Description

Indian pharmaceutical manufacturer with ophthalmic and ENT product portfolios. Comparable as a domestic Indian generic ophthalmic manufacturer competing for ophthalmologist prescriptions and export tenders.

TypeDirect peer
Description

Indian pharmaceutical company with a meaningful ophthalmic and ENT product portfolio including eye drops and lubricants. Comparable as a domestic Indian manufacturer competing for ophthalmologist prescriptions and pharmacy distribution.

TypeBroad incumbent
Description

Global pharmaceutical major whose Allergan acquisition brought a market-leading ophthalmic pharmaceutical portfolio (including Refresh, Lumigan, Alphagan). Competes indirectly in Indian ophthalmology through branded premium products and represents the global benchmark Syntho's generics are formulated against.

TypeDirect peer
Description

Major Indian pharmaceutical manufacturer with a significant ophthalmic product portfolio spanning antibiotics, anti-allergy, and glaucoma. Competes with Syntho in both Indian branded ophthalmics and international generic exports.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syntho Pharmaceuticals

Ophthalmic Pharmaceuticalseyepharma.in

What Syntho Pharmaceuticals does

Syntho Pharmaceuticals Pvt. Ltd. is a privately held, founder-controlled specialty pharmaceutical company headquartered in Lucknow, Uttar Pradesh, that develops, manufactures, and commercializes branded ophthalmic products for the Indian market and generic ophthalmic formulations for export markets. The company operates a WHO GMP certified production plant with an independent QC section and ISO 9001:2015 certification, producing eye drops and ointments across antibiotics, corticosteroids, NSAIDs, lubricants, and anti-glaucoma categories under brands such as MOSS, THOMOXX, ATROCIN, DEXCIN, and Obra.

The company runs a sales-led go-to-market model in India, deploying a network of medical representatives targeting ophthalmologists in cities including Lucknow, Delhi, Haryana, Jaipur, Bikaner, and Jodhpur, supported by a claimed distribution network of 10,000+ distributors and a contact database of 15,000+ ophthalmologists. Internationally, Syntho ships generic ophthalmic drops and ointments through export houses, providing dossiers, Certificates of Analysis, and Certificates of Pharmaceutical Product (COPP) under USP and BP standards across markets spanning several countries.

The business makes money primarily through one-time sales of branded pharmaceutical SKUs at quote-based pricing, with no subscription, licensing, or recurring revenue model disclosed. Founded in 1975 by Mr. Dinesh Agarwal and led today by a family management team, Syntho has 45+ years of lineage, 11-50 employees, and no external institutional funding on record. The company's stated differentiators are regulatory compliance, distribution depth, and longevity in a specialized therapeutic category, rather than proprietary technology or differentiated pricing power.

Syntho Pharmaceuticals firmographics

Firmographics
Name
Syntho Pharmaceuticals
Legal name
Syntho Pharmaceuticals Pvt. Ltd.
Website
https://eyepharma.in
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Syntho Pharmaceuticals industry classification

Industry
Product category
Ophthalmic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIABAF
Ophthalmic & Otic Generics
SECONDARYHLAIADAF
Eye, Ear & Nasal Care
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • Ophthalmic pharmaceuticals
  • Eye drops manufacturing
  • Ear drops formulations
  • Pharmaceutical manufacturing India
  • Ophthalmic solutions

Where Syntho Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Lucknow
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Syntho Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Ophthalmic Pharmaceutical Products: Sale of branded pharmaceutical products for ophthalmology including eye drops and ointments through domestic distribution and export channels
  2. Export Products: Generic ophthalmic drops and ointments exported to several countries through export houses, with documentation including dossiers, Certificate of Analysis, and COPP

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based pharmaceutical pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Syntho Pharmaceuticals product offering

Product offering

Core offering

Syntho Pharmaceuticals develops, manufactures, and commercializes branded ophthalmic pharmaceutical products including eye drops, eye ointments, and ear drops for the Indian domestic market, and exports generic ophthalmic and otic formulations to international markets through export houses. The product portfolio spans antibiotics, corticosteroids, NSAIDs, lubricants, glaucoma medications, and combination products, manufactured at a WHO GMP certified facility in Lucknow, India.

Product overview

Syntho Pharmaceuticals is a specialty pharmaceutical company focused on developing, manufacturing, and commercializing branded ophthalmic pharmaceutical products. The company's product portfolio consists of over 30 distinct eye and ear drop formulations and ointments sold in India, along with generic ophthalmic products for international export. The India market portfolio includes antibiotic formulations (ATROCIN, DEXCIN, Mycin, Ktromoxx), corticosteroid combinations (CORTECYCLINE, Obra-D, F-LONE), NSAID formulations (NSAID-N, Phenosulf), lubricant eye drops (MOSS family including MOSS, MOSS FRESH Gel, MOSS PG, MOSS PLUS), glaucoma treatments (Timo-5, THOMOXX, THOMOXX-L), and combination products (Mezol, NUGEN, OLOTAD, P-LONE, QUGAT, Phentrop, HY-MOSS). The company also exports generic ophthalmic formulations internationally under USP and BP standards. The portfolio spans multiple therapeutic categories including antibiotics, anti-inflammatory agents, lubricants, and glaucoma medications.

Differentiator

Problem solved

Functional benefit

Products and services

  • ATROCIN P Eye Ointment Branded ophthalmic ointment formulation in the antibiotic category, sold through Syntho's domestic distribution network in India for treatment of eye conditions.
  • ATROCIN Eye Ointment Branded ophthalmic ointment formulation in the antibiotic category for the Indian domestic market, distributed through Syntho's medical representatives and distributors.
  • CORTECYCLINE Eye Ointment Branded ophthalmic ointment in the corticosteroid combination category for Indian domestic ophthalmic use.
  • DEXCIN Eye & Ear Drops Combination ophthalmic and otic drop formulation in the antibiotic/corticosteroid category for Indian domestic treatment of eye and ear conditions.
  • DEXCIN-M Eye Drops Branded ophthalmic combination drop formulation in the antibiotic/corticosteroid category, sold in India.
  • F-LONE Eye Drops Corticosteroid ophthalmic drop formulation for the Indian domestic market for treatment of inflammatory eye conditions.
  • HY MOSS Eye Drops Branded ophthalmic drop formulation in the HY MOSS / MOSS family for Indian domestic use.
  • HY MOSS T Drops Newly launched branded ophthalmic drop formulation in the HY MOSS product family, sold in India.
  • Ktromoxx Eye Drops Antibiotic ophthalmic drop formulation distributed in the Indian domestic market through Syntho's field force and distributors.
  • LOW-DEX Eye & Ear Drops Corticosteroid ophthalmic and otic drop formulation for the Indian domestic market.
  • Mezol Eye Drops Combination ophthalmic drop formulation sold in the Indian domestic market for treatment of multiple eye conditions.
  • MOSS FRESH Gel Lubricant Eye Drops Gel-based lubricant eye drop in the MOSS family for dry eye relief, sold in India.
  • MOSS Lubricant Eye Drops Lubricant eye drop formulation in the MOSS family for dry eye relief, sold in India.
  • MOSS PG Lubricant Eye Drops Lubricant eye drop formulation in the MOSS family, distributed in India for dry eye conditions.
  • MOSS PLUS Lubricant Eye Drops Lubricant eye drop formulation in the MOSS family for dry eye relief, sold in India.
  • Mycin Eye Drops Antibiotic ophthalmic drop formulation in the Indian domestic market for treatment of bacterial eye infections.
  • NS-AID Eye Drops NSAID ophthalmic drop formulation sold in India for inflammation-related eye conditions.
  • NSAID-N Eye Drops NSAID ophthalmic drop formulation distributed in India.
  • NUGEN Eye & Ear Drops Combination ophthalmic and otic drop formulation for the Indian domestic market.
  • Obra-D Eye Ointment Ophthalmic ointment formulation in the Obra family for Indian domestic ophthalmic treatment.
  • Obra Eye Drops & Ointment Ophthalmic drop and ointment combination product in the Obra family, sold in India.
  • Obra-F Eye Drops Ophthalmic drop formulation in the Obra family sold in India.
  • OLOTAD Eye Drops Combination ophthalmic drop formulation sold in India for treatment of eye conditions.
  • P-LONE Eye Drops Corticosteroid ophthalmic drop formulation sold in India.
  • Phenosulf Eye Drops NSAID ophthalmic drop formulation distributed in India.
  • Phentrop Eye Drops Newly launched branded ophthalmic drop formulation sold in India.
  • QUGAT Eye Drops Combination ophthalmic drop formulation sold in India.
  • THOMOXX Eye Ointment Ophthalmic ointment formulation in the THOMOXX family for the Indian domestic market.
  • THOMOXX Eye Drops Ophthalmic drop formulation in the THOMOXX family for the Indian domestic market.
  • THOMOXX-L Eye Drops Newly launched ophthalmic drop formulation in the THOMOXX family for the Indian domestic market.
  • Timo-5 Eye Drops Glaucoma treatment ophthalmic drop formulation (beta-blocker) sold in India.
  • Calodin Eye Drops Branded ophthalmic drop formulation sold in India through Syntho's distribution network.
  • Chloramphenicol Otic Solution 0.1% USP (Export) Generic antibiotic otic solution exported internationally under USP standards for treatment of ear infections.
  • Chloramphenicol Eye Drops 0.5% USP (Export) Generic antibiotic ophthalmic drops exported internationally under USP standards for bacterial eye infections.
  • Ciprofloxacin Eye Drops 3mg/ml USP (Export) Fluoroquinolone antibiotic ophthalmic drops exported under USP standards for bacterial eye infections.
  • Clotrimazole Ear Drops 1% w/v (Export) Antifungal otic drops exported internationally for treatment of fungal ear infections.
  • Dexamethasone 0.1% w/v & Chloramphenicol 1% w/v Eye Drops (Export) Combination corticosteroid and antibiotic ophthalmic drops exported internationally for inflammatory eye conditions complicated by bacterial infection.
  • Dexamethasone Eye Drops 0.1% w/v (Export) Corticosteroid ophthalmic drops exported under USP standards for inflammatory eye conditions.
  • Timolol Maleate Ophthalmic Solution 0.5% USP (Export) Beta-blocker ophthalmic drops exported under USP standards for treatment of glaucoma and ocular hypertension.
  • Cromolyn Sodium Ophthalmic Solution USP 4% w/v (Export) Mast cell stabilizer ophthalmic drops exported under USP standards for treatment of allergic conjunctivitis.
  • Chloramphenicol Ophthalmic Ointment USP 1% w/v (Export) Generic antibiotic ophthalmic ointment exported internationally under USP standards for eye infections.
  • Tetracycline Eye Ointment 1% USP (Export) Generic antibiotic ophthalmic ointment exported under USP standards for bacterial eye infections.
  • Prednisolone Sodium Phosphate Eye Drops BP 0.1% w/v (Export) Corticosteroid ophthalmic drops exported under BP standards for treatment of ocular inflammation.
  • Betamethasone Ear Drops 0.1% (Export) Corticosteroid otic drops exported internationally for treatment of inflammatory ear conditions.
  • Carboxymethyl Cellulose 1% (Export) Lubricant ophthalmic drops exported internationally for dry eye relief.
  • Chloramphenicol Ear Drops 5% (Export) Generic antibiotic otic drops exported internationally for bacterial ear infections.
  • Ciprofloxacin Eye Drops BP 0.2% w/v (Export) Fluoroquinolone antibiotic ophthalmic drops exported under BP standards.
  • Moxifloxacin Ophthalmic Solution USP (Export) Fourth-generation fluoroquinolone ophthalmic drops exported under USP standards for bacterial eye infections.
  • Tobramycin + Dexamethasone Eye Drops (Export) Combination antibiotic and corticosteroid ophthalmic drops exported internationally for inflammatory eye conditions with bacterial infection risk.

Companies that use Syntho Pharmaceuticals

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Syntho Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Syntho Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Delhi Ophthalmological Society (DOS)coreStrategic or Co-development Partner · 20 March 2021Syntho Pharmaceuticals participated as a supporter in the Delhi Ophthalmological Society Midterm Conference 2021 held on March 20-21, 2021 at Hotel Ashoka, New Delhi. The two-day event saw participation from ophthalmologists across India and abroad through online and offline sessions.
  • Ophthalmological Societies Network (GSI, UPSOS, UKSOS, DOS, AIOS)minorStrategic or Co-development PartnerActive involvement in knowledge sharing and development through various ophthalmological societies including Glaucoma Society of India (GSI), UP State Ophthalmological Society (UPSOS), UK State Ophthalmological Society (UKSOS), Delhi Ophthalmological Society (DOS), and All India Ophthalmological Society (AIOS).

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Syntho Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Intas Pharmaceuticals: Large Indian pharmaceutical company with ophthalmic products spanning glaucoma, anti-infectives, and dry eye. Competes with Syntho for ophthalmologist share in India and generic ophthalmic exports.
  • Entod Pharmaceuticals: India-based specialty pharmaceutical company focused exclusively on ophthalmology, ENT, and dermatology. Closely comparable as a smaller, specialty-focused Indian pharma with similar product categories (eye drops, ointments) and sales-led GTM via medical representatives.
  • Centaur Pharmaceuticals: Indian pharmaceutical manufacturer with a dedicated ophthalmic division producing eye drops and ophthalmic preparations. Comparable as a domestic specialty player in the Indian ophthalmic market.
  • Ajanta Pharma: Indian specialty pharmaceutical company with ophthalmology and ENT product lines. Competes in similar ophthalmic therapeutic categories and exports to multiple international markets through documentation similar to Syntho's dossier/COA/COPP approach.
  • Sun Pharmaceutical Industries: India's largest pharmaceutical company with a substantial ophthalmic franchise (Sun Pharma's ophthalmic division markets branded and generic eye drops and ointments). Direct competitor in Indian ophthalmic prescriptions and exports, with significantly larger scale and R&D budget.
  • Micro Labs: Indian pharmaceutical manufacturer with ophthalmic and ENT product portfolios. Comparable as a domestic Indian generic ophthalmic manufacturer competing for ophthalmologist prescriptions and export tenders.
  • FDC Limited: Indian pharmaceutical company with a meaningful ophthalmic and ENT product portfolio including eye drops and lubricants. Comparable as a domestic Indian manufacturer competing for ophthalmologist prescriptions and pharmacy distribution.
  • Cipla: Major Indian pharmaceutical manufacturer with a significant ophthalmic product portfolio spanning antibiotics, anti-allergy, and glaucoma. Competes with Syntho in both Indian branded ophthalmics and international generic exports.

Broad incumbents

  • Alcon: Global leader in eye care with a broad ophthalmic pharmaceutical and surgical portfolio. While significantly larger and focused on premium branded products, it competes indirectly with Syntho for ophthalmologist mindshare in India and serves as the innovation benchmark that domestic players chase.
  • AbbVie (Allergan Aesthetics/eye care): Global pharmaceutical major whose Allergan acquisition brought a market-leading ophthalmic pharmaceutical portfolio (including Refresh, Lumigan, Alphagan). Competes indirectly in Indian ophthalmology through branded premium products and represents the global benchmark Syntho's generics are formulated against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Syntho Pharmaceuticals social profiles

Digital presence

Syntho Pharmaceuticals compliance and trust

Trust signal

Compliance2 records

Syntho Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syntho Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles3 records

Syntho Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syntho Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syntho Pharmaceuticals

What does Syntho Pharmaceuticals do?

Syntho Pharmaceuticals develops, manufactures, and commercializes branded ophthalmic pharmaceutical products including eye drops, eye ointments, and ear drops for the Indian domestic market, and exports generic ophthalmic and otic formulations to international markets through export houses. The product portfolio spans antibiotics, corticosteroids, NSAIDs, lubricants, glaucoma medications, and combination products, manufactured at a WHO GMP certified facility in Lucknow, India.

Is Syntho Pharmaceuticals a public or private company?

Syntho Pharmaceuticals is a private company. It is classified as family owned and is currently operating.

When was Syntho Pharmaceuticals founded?

Syntho Pharmaceuticals was founded in 1975. It employs 11 to 50 people.

Where is Syntho Pharmaceuticals based?

Syntho Pharmaceuticals is headquartered in Lucknow, India, in the Asia region.

How does Syntho Pharmaceuticals make money?

Two revenue lines are on record. Ophthalmic Pharmaceutical Products are the primary driver. The others are export Products.

Who are Syntho Pharmaceuticals's main competitors?

Direct peers on record are Intas Pharmaceuticals, Entod Pharmaceuticals, Centaur Pharmaceuticals, Ajanta Pharma, Sun Pharmaceutical Industries, Micro Labs, FDC Limited and Cipla. Broad incumbents are Alcon and AbbVie (Allergan Aesthetics/eye care).

Does Syntho Pharmaceuticals have an API?

No public API is recorded for Syntho Pharmaceuticals.

What industry is Syntho Pharmaceuticals in?

Syntho Pharmaceuticals's product category is Ophthalmic Pharmaceuticals. Its primary akta.pro industry code is HLAIACAK, Ophthalmology Specialty Pharmaceuticals, with a secondary code of HLAIABAF, Ophthalmic & Otic Generics. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales